ARTHROPLASTY
Topical tranexamic acid reduces blood loss and transfusion rate following THA
J Bone Joint Surg Am. 2013 Nov 6;95(21):1969-74One hundred and sixty-one patients scheduled to receive unilateral primary total hip replacement were randomly assigned into 1 of 2 groups, a tranexamic group or a placebo, to test the effect of topical application of tranexamic acid has on blood loss and transfusion in patients undergoing total hip arthroplasty. The results of the study indicated that topical administration of tranexamic acid was effective in reducing blood loss and need for blood transfusion following total hip replacement, and also successfully avoided the complications intravenous tranexamic acid administration can lead to.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
